Last updated on September 2017

Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)


Brief description of study

The purpose of this study is to assess the safety and efficacy of monotherapy pembrolizumab (MK-3475) in participants with renal cell carcinoma (RCC). There will be two cohorts in this study: Cohort A will consist of participants with clear cell (cc) RCC and Cohort B will consist of participants with non-clear cell (ncc) RCC.

Clinical Study Identifier: NCT02853344

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Toll Free Number

Call for Information (Investigational Site 8005)
Tucson, AZ United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0095)
Washington, D.C., United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0049)
Washington, D.C., United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 8007)
Miami, FL United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0053)
Chicago, IL United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0050)
New Orleans, LA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0084)
Boston, MA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0096)
Boston, MA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0017)
Detroit, MI United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0014)
Billings, MT United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 8009)
Las Vegas, NV United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0032)
New York, NY United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0099)
Philadelphia, PA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 8008)
Charleston, SC United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0090)
Chattanooga, TN United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0093)
Burlington, VT United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 8006)
Roanoke, VA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0021)
Kennewick, WA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0045)
Seattle, WA United States
  Connect »

Toll Free Number

Call for Information (Investigational Site 0026)
Milwaukee, WI United States
  Connect »

Thomas Johansson

MSD SRO Czech
Prague, Czechia
  Connect »

Nathan Lassota

Merck Sharp & Dohme
Glostrup, Denmark
  Connect »

German Medical Information Center

MSD Sharp & Dohme GmbH
Haar, Germany
  Connect »

Jongho Ahn

MSD Korea LTD
Seoul, Korea, Republic of
  Connect »

Thomas Johansson

MSD Polska Sp. Z o.o.
Warsaw, Poland
  Connect »

Tatiana Serebriakova

Merck Sharp & Dohme IDEA, Inc.
Moscow, Russian Federation
  Connect »

Joaquin Mateos Chacon

Merck Sharp and Dohme de Espana S.A.
Madrid, Spain
  Connect »

Mark Toms

Merck Sharp & Dohme Ltd.
Hoddesdon, United Kingdom
  Connect »